Breaking stories
Donate Subscribe
Putting a price on COVID drug remdesivir Putting a price on COVID drug remdesivir

Putting a price on COVID drug remdesivir

Consumer Corner May 9, 2020 NPR 0

Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step... Putting a price on COVID drug remdesivir

Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That’s when most drugs get price tags.


Sign up for our free email alerts and follow us on Facebook and on Twitter @gahealthnews.
Help us fulfill our nonprofit mission with a tax-deductible donation!
About author

NPR

Add a comment

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

Please leave these two fields as-is:

Foundation Support for GHN:
Georgia Health Foundation
Ford Foundation
Healthcare Georgia Foundation
Fund for Investigative Journalism
Kaiser Permanente
Thanks Mom & Dad Fund

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

EVERY LITTLE BIT HELPS
Donations Welcome

Donate Icon

Copyright 2019 Georgia Health News a non-profit, 501 (c)3 organization.